Company / Shares Outstanding
NewAmsterdam Pharma Co N.V. Shares Outstanding History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
118.4M
FY2025
5-year range
11.0M / 118.4M
FY2021-FY2025
Trend
+25.5%
vs FY2024
Sector context
#84 of 208
Health Care
What the data says
At 118424231.00, NewAmsterdam Pharma Co N.V.'s shares outstanding ranks #125 of 208 in the Health Care sector. Shares Outstanding has increased for 4 consecutive years, from 10978874.00 in FY2021 to 118424231.00 in FY2025.
Based on SEC 10-K filings.
118424231.00 in FY2025 with a 3-year CAGR of +84.1%.
Increased from 82161956.00 to 118424231.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +84.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#125 of 208 in Health CareTop 60% of 208This company 118.4M Sector average 311.6M
▼
-62.0% below sector average
Key checks
Key Insights
- NewAmsterdam Pharma Co N.V.'s shares outstanding has grown for 4 consecutive years.
- In FY2025, shares outstanding increased 25.5% year-over-year.
- Ranks #84 out of 208 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 118.4M | +25.5% |
| FY2024 | 94.4M | +14.8% |
| FY2023 | 82.2M | +333.2% |
| FY2022 | 19.0M | +72.8% |
| FY2021 | 11.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026